Recently, Liverscan®, the flagship product of Eieling Technology, equipped with the world’s exclusive patented technology, was successfully installed in Shulan (Boao) Hospital, providing full support for the whole process management of liver diseases in the hospital and helping the innovation and upgrading of clinical technology in the department.
Since its official opening, Shulan (Boao) Hospital has been committed to providing patients with internationally advanced medical technology services. The hospital focuses on tumors, rare diseases, anti-aging treatment and high-end rehabilitation services, and constantly innovates medical service methods to meet the different needs of patients to achieve the goal of “no serious illness outside the island” and “no serious illness outside the country”.
Shulan (Boao) Hospital has always attached great importance to the screening and diagnosis and treatment of chronic liver disease, and introduced Liverscan® to enable the full management of liver-related diseases and help to efficiently and accurately judge and manage the condition.
This installation has become a new starting point for Eieling Technology and Shulan (Boao) Hospital to carry out in-depth cooperation and research in medical equipment renewal and technology improvement. At present, Eieling has carried out product strategic deployment in North America, Southeast Asia, mainland China, Hong Kong, Macao, and Taiwan, and the process of efficient diagnosis and treatment solutions benefiting liver disease patients around the world is gradually advancing.
In the future, Eieling Technology will continue to establish long-term and stable relationships with its partners, solve the challenges of chronic liver diseases such as hepatitis, fatty liver, and other related diseases through resource sharing and complementary advantages, accelerate the global layout, and promote China’s new quality productivity to the world.
New option for non-invasive liver disease diagnosis
The patented transient elastography (TE) technology is an important non-invasive diagnostic technology for liver fibrosis. It reflects the degree of liver fibrosis by measuring the liver stiffness value (LSM). It is non-invasive, simple, rapid, and easy to operate. It has been recommended by AASLD, EASL, and the Chinese Guidelines for the Prevention and Treatment of Chronic Hepatitis B as an important means of clinical evaluation of hepatitis B and C virus-related liver fibrosis. [1]
Liverscan® integrates two technologies, transient elastic imaging and real-time ultrasound image guidance, into one wireless probe, which greatly reduces the cost of product deployment, maintenance, and learning, and has a rich and diverse application scenario. As a leader in elastic imaging wireless ultrasound application equipment in the field of chronic liver disease, Liverscan® has been put into use in clinical departments, grassroots screening, drug experiments, physical examination institutions, and medical education, providing more patients with innovative liver disease comprehensive solutions and services.
About Eieling Technology
Eieling Technology was selected as one of the “100 Most Noteworthy Asian Companies in 2023” by Forbes Asia for its outstanding performance and extensive influence in the industry. Its star product in the field of liver disease diagnosis is the Liverscan® is the world’s first wireless portable liver elasticity instrument and is widely used in bedside ultrasound examinations, outpatient rapid screening, and grassroots screening. It has the first TE detection composite multi-channel probe in China, which enables convenient, accurate, and non-invasive liver testing, and promotes the progress of early liver disease screening and prevention and treatment. Equipped with the patented technology of transient elastic imaging under two-dimensional ultrasound guidance (a global original), it realizes intelligent and efficient liver disease diagnosis and helps the full management of chronic liver disease.
[1] China Hepatitis Prevention and Treatment Foundation, Chinese Society of Infectious Diseases, Chinese Society of Hepatology, and Chinese Association of Research Hospitals. Expert consensus on diagnosis of liver fibrosis using transient elastography (2018 update)[J]. Chinese Journal of Hepatology, 2019, 027(003):182-191.